Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.

<h4>Background</h4>We designed a seroprevalence study using multiple testing assays and population sources to estimate the community seroprevalence of pH1N1/09 and risk factors for infection before the outbreak was recognized and throughout the pandemic to the end of 2009/10 influenza se...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Camille Achonu, Laura Rosella, Jonathan B Gubbay, Shelley Deeks, Anu Rebbapragada, Tony Mazzulli, Don Willison, Julie Foisy, Allison McGeer, Ian Johnson, Marie LaFreniere, Caitlin Johnson, Jacqueline Willmore, Carmen Yue, Natasha S Crowcroft
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/39e93c319a324ec082b4be6b273420a7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:39e93c319a324ec082b4be6b273420a7
record_format dspace
spelling oai:doaj.org-article:39e93c319a324ec082b4be6b273420a72021-11-18T07:34:25ZSeroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.1932-620310.1371/journal.pone.0026427https://doaj.org/article/39e93c319a324ec082b4be6b273420a72011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22110586/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>We designed a seroprevalence study using multiple testing assays and population sources to estimate the community seroprevalence of pH1N1/09 and risk factors for infection before the outbreak was recognized and throughout the pandemic to the end of 2009/10 influenza season.<h4>Methods</h4>Residual serum specimens from five time points (between 01/2009 and 05/2010) and samples from two time points from a prospectively recruited cohort were included. The distribution of risk factors was explored in multivariate adjusted analyses using logistic regression among the cohort. Antibody levels were measured by hemagglutination inhibition (HAI) and microneutralization (MN) assays.<h4>Results</h4>Residual sera from 3375 patients and 1024 prospectively recruited cohort participants were analyzed. Pre-pandemic seroprevalence ranged from 2%-12% across age groups. Overall seropositivity ranged from 10%-19% post-first wave and 32%-41% by the end of the 2009/10 influenza season. Seroprevalence and risk factors differed between MN and HAI assays, particularly in older age groups and between waves. Following the H1N1 vaccination program, higher GMT were noted among vaccinated individuals. Overall, 20-30% of the population was estimated to be infected.<h4>Conclusions</h4>Combining population sources of sera across five time points with prospectively collected epidemiological information yielded a complete description of the evolution of pH1N1 infection.Camille AchonuLaura RosellaJonathan B GubbayShelley DeeksAnu RebbapragadaTony MazzulliDon WillisonJulie FoisyAllison McGeerIan JohnsonMarie LaFreniereCaitlin JohnsonJacqueline WillmoreCarmen YueNatasha S CrowcroftPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 11, p e26427 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Camille Achonu
Laura Rosella
Jonathan B Gubbay
Shelley Deeks
Anu Rebbapragada
Tony Mazzulli
Don Willison
Julie Foisy
Allison McGeer
Ian Johnson
Marie LaFreniere
Caitlin Johnson
Jacqueline Willmore
Carmen Yue
Natasha S Crowcroft
Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.
description <h4>Background</h4>We designed a seroprevalence study using multiple testing assays and population sources to estimate the community seroprevalence of pH1N1/09 and risk factors for infection before the outbreak was recognized and throughout the pandemic to the end of 2009/10 influenza season.<h4>Methods</h4>Residual serum specimens from five time points (between 01/2009 and 05/2010) and samples from two time points from a prospectively recruited cohort were included. The distribution of risk factors was explored in multivariate adjusted analyses using logistic regression among the cohort. Antibody levels were measured by hemagglutination inhibition (HAI) and microneutralization (MN) assays.<h4>Results</h4>Residual sera from 3375 patients and 1024 prospectively recruited cohort participants were analyzed. Pre-pandemic seroprevalence ranged from 2%-12% across age groups. Overall seropositivity ranged from 10%-19% post-first wave and 32%-41% by the end of the 2009/10 influenza season. Seroprevalence and risk factors differed between MN and HAI assays, particularly in older age groups and between waves. Following the H1N1 vaccination program, higher GMT were noted among vaccinated individuals. Overall, 20-30% of the population was estimated to be infected.<h4>Conclusions</h4>Combining population sources of sera across five time points with prospectively collected epidemiological information yielded a complete description of the evolution of pH1N1 infection.
format article
author Camille Achonu
Laura Rosella
Jonathan B Gubbay
Shelley Deeks
Anu Rebbapragada
Tony Mazzulli
Don Willison
Julie Foisy
Allison McGeer
Ian Johnson
Marie LaFreniere
Caitlin Johnson
Jacqueline Willmore
Carmen Yue
Natasha S Crowcroft
author_facet Camille Achonu
Laura Rosella
Jonathan B Gubbay
Shelley Deeks
Anu Rebbapragada
Tony Mazzulli
Don Willison
Julie Foisy
Allison McGeer
Ian Johnson
Marie LaFreniere
Caitlin Johnson
Jacqueline Willmore
Carmen Yue
Natasha S Crowcroft
author_sort Camille Achonu
title Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.
title_short Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.
title_full Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.
title_fullStr Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.
title_full_unstemmed Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.
title_sort seroprevalence of pandemic influenza h1n1 in ontario from january 2009-may 2010.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/39e93c319a324ec082b4be6b273420a7
work_keys_str_mv AT camilleachonu seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT laurarosella seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT jonathanbgubbay seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT shelleydeeks seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT anurebbapragada seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT tonymazzulli seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT donwillison seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT juliefoisy seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT allisonmcgeer seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT ianjohnson seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT marielafreniere seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT caitlinjohnson seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT jacquelinewillmore seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT carmenyue seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
AT natashascrowcroft seroprevalenceofpandemicinfluenzah1n1inontariofromjanuary2009may2010
_version_ 1718423279164719104